Stock Updates

How has Zimmer Biomet Holdings, Inc.:(NYSE:ZBH) performed recently?

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a large market cap stock with a market cap of 26004.61. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 116.7, a forward P/E of 14.74 and EPS of 1.11. At a stock price of 128.97 (-0.62%) it has a dividend yield of 0.74%.

EPS growth for the last five years have been -23.60%, more recently this last year it has grown by -81.50%. The next year growth is going to be about 10.45% and more long-term 11.07% after five years. EPS growth quarter over quarter is 83.00%. Sales growth for the past five years have been 7.30% and sales growth quarter over quarter is -44.30%.

For performance, Zimmer Biomet Holdings, Inc. the past week has seen a gain of 1.15%. For the last month performance for Zimmer Biomet Holdings, Inc. is 5.20%. While the last quarter is 7.68% and half year, 38.14%. Finally for the year, performance is 31.48%.

The 52-week high for Zimmer Biomet Holdings, Inc., is at -3.17%, and for the 52-week low it comes to a value of 46.74%. The 20-day simple moving average is 3.55% and 16.90% for the 200-day simple moving average.

Volatility for the week is at 1.14%, and for the month it is 1.23%. Zimmer Biomet Holdings, Inc., has a target price of 140.25.

In terms of debt, long term debt/equity is 1.1, and for total debt/equity Zimmer Biomet Holdings, Inc. has 1.16. The gross margin is 68.00%, while operating margin is 13.60%, the profit margin is 4.40%. The current ratio is 2.4 and the quick ratio is 1.5.

Insider ownership is at 0.20%, with instituitional ownership at 90.30%. Zimmer Biomet Holdings, Inc. has a payout ratio of 70.30%. With the total shares outstanding coming to 200.39. The shares float is 199.57, with the float short at 2.40%, with short ratio coming to 2.92.

In terms of returns, the return on assets see Zimmer Biomet Holdings, Inc., get 1.30%, with its returns on investment at 2.10%. Return on equity is 3.40%. So will the investors see the target price of 140.25, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment